This is an important topic, as several commonly prescribed medications—especially those used to treat non-cardiovascular conditions—can increase the risk of myocardial infarction (heart attack) or stroke in older adults, often due to effects on blood pressure, clotting, heart rate, or electrolyte balance.
Disclaimer: Do not stop or change any medication without consulting the prescribing physician. The risks described are often dose- and duration-dependent, and for many patients, the benefits outweigh the risks. This information is for awareness, not medical advice.
Based on cardiology and geriatric pharmacology literature, here are five medication classes that raise cardiovascular risk in older patients:
1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Examples: Ibuprofen (Advil, Motrin), naproxen (Aleve), diclofenac, celecoxib (Celebrex), meloxicam
Why they increase risk:
-
Cause sodium and fluid retention → increased blood pressure
-
Reduce protective prostacyclins → promote thrombosis (clot formation)
-
Worsen heart failure and may blunt the effect of diuretics and ACE inhibitors
Risk increase:
-
~20–50% higher risk of heart attack and stroke with chronic use, especially at high doses
-
Risk highest with rofecoxib (Vioxx – withdrawn) and diclofenac; lowest with naproxen but still present
Who’s most vulnerable:
-
Patients with existing heart disease, heart failure, hypertension, or chronic kidney disease
Safer alternatives (when possible):
-
Acetaminophen (Tylenol) for pain
-
Topical NSAIDs (diclofenac gel) – minimal systemic absorption
-
Short-term, low-dose NSAIDs with gastroprotection if unavoidable
2. Certain Oral Diabetes Medications (Sulfonylureas & Others)
Examples: Glyburide (glibenclamide), glipizide, glimepiride
Why they increase risk:
-
Can cause severe hypoglycemia → triggers catecholamine surge (adrenaline) → increased heart rate, blood pressure, and risk of cardiac ischemia or arrhythmia
-
Glyburide also interferes with cardioprotective ischemic preconditioning (blocks K-ATP channels in the heart)
Risk increase:
-
Sulfonylureas associated with ~30–40% higher risk of major adverse cardiovascular events (MACE) compared to metformin or newer agents like SGLT2 inhibitors or GLP-1 agonists
Preferred alternatives in older patients with cardiac risk:
-
Metformin (first-line)
-
SGLT2 inhibitors (empagliflozin, dapagliflozin) – proven to reduce heart failure hospitalizations
-
GLP-1 agonists (liraglutide, semaglutide) – reduce MACE
Note: Modern sulfonylureas like glipizide and glimepiride have lower hypoglycemia risk than glyburide but are still inferior to newer agents.
3. Stimulant Medications (for ADHD, Narcolepsy, or Weight Loss)
Examples: Amphetamine/dextroamphetamine (Adderall), methylphenidate (Ritalin, Concerta), phentermine (Adipex-P), pseudoephedrine (Sudafed – OTC)
Why they increase risk:
-
Increase heart rate, blood pressure, and myocardial oxygen demand
-
Can trigger tachyarrhythmias (atrial fibrillation, ventricular tachycardia)
-
Constrict coronary arteries – dangerous in patients with plaque
Risk increase:
-
Modest absolute risk in young healthy patients, but significantly higher in older adults with underlying hypertension or coronary artery disease
-
Phentermine (weight loss) has been linked to valvular heart disease (especially when combined with fenfluramine – withdrawn)
Clinical caution:
-
Avoid or use lowest possible dose in older adults with known heart disease
-
Consider non-stimulant alternatives: atomoxetine (Strattera), guanfacine, bupropion
4. Some Antiarrhythmic Drugs (Especially Class Ia & Ic)
Examples: Disopyramide, flecainide, propafenone
Why they increase risk:
-
Proarrhythmic effects – they can actually cause life-threatening arrhythmias, including ventricular tachycardia (torsade de pointes for certain agents)
-
Flecainide/propafenone are contraindicated in patients with prior myocardial infarction (CAST trial showed increased mortality)
-
Disopyramide has potent negative inotropic effects (weakens heart muscle)
Risk increase:
-
CAST trial (1989): Flecainide/encianide doubled mortality in post-MI patients
-
Currently, these drugs are reserved for structurally normal hearts (e.g., lone atrial fibrillation or paroxysmal SVT in younger patients)
Safer alternatives for older adults with atrial fibrillation:
-
Beta-blockers (metoprolol, atenolol)
-
Dronedarone (for certain patients, but caution in heart failure)
-
Amiodarone (effective but toxicities require monitoring)
-
Rate control often preferred over rhythm control in elderly
5. Antipsychotic Medications (Typical & Atypical)
Examples: Haloperidol (Haldol), risperidone (Risperdal), quetiapine (Seroquel), olanzapine (Zyprexa), aripiprazole (Abilify)
Why they increase risk:
-
Metabolic effects: Weight gain, dyslipidemia, diabetes → accelerate atherosclerosis
-
Orthostatic hypotension → fall risk, but also reflex tachycardia and myocardial strain
-
QT prolongation (especially haloperidol, ziprasidone) → risk of torsade de pointes
-
Increased risk of venous thromboembolism (DVT/PE)
Risk increase:
-
Meta-analyses show ~1.5–2.0× higher risk of stroke in elderly patients with dementia (FDA black box warning)
-
Increased risk of sudden cardiac death (dose-dependent)
Special warning in geriatric patients:
-
Off-label use for dementia-related agitation → stroke risk highest in first weeks
-
Non-pharmacologic approaches should be tried first
Lower-risk alternatives (if antipsychotic unavoidable):
-
Low-dose quetiapine (less extrapyramidal but still metabolic risk)
-
Avoid haloperidol IV (high QT risk)
-
Monitor EKG for QTc > 450 ms (men) or > 470 ms (women)
Other Medications Worth Mentioning (Honorable Mentions)
| Medication Class | Example | Risk |
|---|---|---|
| Hormone replacement therapy | Conjugated estrogens | Increased stroke, DVT (now rarely used) |
| Macrolide antibiotics | Clarithromycin, erythromycin | QT prolongation, drug interactions |
| Certain chemotherapy agents | 5-FU, capecitabine | Coronary vasospasm |
| Triptans (migraine) | Sumatriptan | Coronary vasoconstriction (contraindicated in CAD) |
Practical Takeaways for Patients & Families
-
Ask your doctor: “Does this medication increase my risk of heart attack or stroke, given my age and health history?”
-
Review medications annually with a pharmacist or cardiologist.
-
Don’t stop NSAIDs or antipsychotics abruptly – withdrawal or undertreated pain/psychosis also carries risks.
-
For minor pain, prefer acetaminophen or topical NSAIDs.
-
For diabetes in older adults with heart risk, ask about SGLT2 inhibitors or GLP-1 agonists instead of sulfonylureas.
-
Monitor for symptoms – new chest pain, shortness of breath, palpitations, or neurological deficits after starting any new medication.
When the Benefit Outweighs the Risk
These medications are not “poisons” – they save lives in the right context. For example:
-
Antipsychotics may be necessary for severe schizophrenia or psychosis.
-
NSAIDs may be the only relief for disabling osteoarthritis (but use lowest dose/shortest duration).
-
Sulfonylureas remain low-cost options where newer drugs are unavailable.
The key is individualized risk assessment – especially in older adults with polypharmacy, frailty, and multiple comorbidities.
Would you like a medication review checklist for older adults, or a list of cardioprotective medications (like statins, SGLT2 inhibitors, or beta-blockers) that are often underused in this population?